González GYJ, García RI, García FWO

Idioma: Español
Referencias bibliográficas: 32
Paginas: 81-85
Archivo PDF: 192.03 Kb.

RESUMEN

Las pruebas serológicas se han convertido en herramientas fundamentales en el diagnóstico y manejo de la infección por el virus de la hepatitis c (VHC). Estas pruebas incluyen la detección de anticuerpos contra el VHC en suero, la detección y cuantificación del ARN-VHC, así como la determinación del genotipo del VHC en suero. Estas pruebas son fundamentales en el diagnóstico y manejo terapéutico de la hepatitis c. En este artículo hacemos una revisión del tema.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Strader, D.B., Wright, T., Thomas, D.L. y Seeff, L.B., “Diagnosis, management and treatment of hepatitis c”, Hepatology, 2004, 39 (4): 1147-1171.

2. Komurian-Pradel, F., Paranhos-Baccala, G. et al., “Quantitation of hcv arn using real-time pcr and fluorimetry”, J Virol Methods, 2001, 95 (1-2): 111-119.

3. Halfon, P., Bourliere, M. et al., “Real-time pcr assays for hcv arn quantitation are adecuate for clinical management of patients with chronic hcv infection”, J Clin Microbiology, 2006, 44 (7): 2507-2511.

4. Pawlotsky, J.M., “Molecular diagnosis of viral hepatitis”, Gastroenterology, 2003, 122: 1554-1568.

5. Carey, W., “Tests and screening strategies for the diagnosis for hepatitis c”, Cleveland Clin J Medicine, 2003, 70 (4): 7-13.

6. Pawlotsky, J.M., “Use and interpretation of virological tests for hepatitis c”, Hepatology, 2002, 36 (5): s65-s73.

7. Sun, Z.H., Ma, W. y Zheng, W., “Microarrays development in the diagnosis of hbv and hcv”, Med J Chin pla, 2003, 28: 375-376.

8. Bukh, J., Miller, R.H. y Purcell, R.H., “Genetic heterogeneity of hepatitis c virus: quasispecies and genotypes”, Semin Liver Dis, 1995, 1 (15): 41-63.

9. Zein, N.N., “Clinical significance of hepatitis c virus genotypes”, Clin Microbiol Rev, 2000, 13: 223-225.

10. Lau, J.Y., Davis, G.L., Prescott, L.E., Maertens, G., Lindsay, K.L., Qian, K., Mizokami, M. et al., “Distribution of hepatitis c virus genotypes determined by line probe assay in patients with chronic hepatitis c seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group”, Ann Intern Med, 1996, 124: 868-876.

11. Nousbaum, J.B., Pol, S., Nalpas, N., Landais, P., Berthelot, P., Brechot, C. y Collaborative Study Group, “Hepatitis c virus type 1b (ii) infection in France and Italy”, Ann Intern Med, 1995, 122: 161-168.

12. Michinori, K., “Hepatitis c virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics”, J Infectious Dis, 1995, 172 (4): 934-938.

13. Qu, D., Li, J.S., Vitvitski, L., Mechai, S., Berby, F., Tong, S.P., Bailly, F. et al., “Hepatitis c virus genotypes in France: comparison of clinical features of patients infected with hcv type i and type ii”, J Hepatol, 1994, 21: 70-75.

14. Davis, G., “Monitoring of viral levels during therapy of hepatitis c”, Hepatology, 2002, 36 (5): s145-s151.

15. Simmonds, P., “Viral heterogeneity of the hepatitis c virus”, J Hepatol, 1999, 31 (1): 54-60.

16. Zein, N.N., “Clinical significance of hepatitis c virus genotypes”, Clin Microbiol Rev, 2000, 13: 223-225.

17. Li, J.S., Vitvitski, L., Tong, S.P. y Trepo, C., “Identification of the third major genotype of hepatitis c virus in France”, Biochem Biophys Res Commun, 1994, 199: 1474-1481.

18. Okamoto, H., Sugiyama, Y., Okada, S., Kurai, K., Akahane, Y., Sugai, Y. et al., “Typing hepatitis c virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources”, J Gen Virol, 1992, 73: 673-679.

19. Widell, A., Shev, S., Mansson, S., Zhang, Y.Y., Foberg, U., Norkrans, G. et al., “Genotyping of hepatitis c virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications”, J Med Virol, 1994, 44: 272-279.

20. McOmish, F., Chan, S.W., Dow, B.C., Gillon, J., Frame, W.D., Crawford, R.J., Yap, P.L. et al., “Detection of three types of hepatitis c virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities”, Transfusion, 1993, 33: 7-13.

21. Nakao, T., Enomoto, N., Takada, N., Takada, A. y Date, T., “Typing of hcv genomes by restriction fragment length polymorphism”, J Gen Virol, 1991, 72: 2105-2112.

22. Stuyver, L., Wyseur, A., Van Arnhem, W., Lunel, F., Laurent- Puig, P., Pawlotsky, J.M., Kleter, B. et al., “Hepatitis c virus genotyping by means of 5’-ur/core line probes assays and molecular analysis of untypeable samples”, Virus Res, 1995; 38: 137-157.

23. Stuyver, L., Wyseur, A., Van Arnhem, W., Hernández, F. y Maertens, G., “Second-generation line probe assay for hepatitis c virus genotyping”, J Clin Microbiol, 1996, 34: 2259-2266.

24. Ansaldi, F., Torre, F., Bruzzone, B.M., Picciotto, A., Crovari, P. e Icardi, G., “Evaluation of a new hepatitis c virus sequencing assay as a routine method for genotyping”, J Med Virol, 2001, 63: 17-21.

25. Maertens, G. y Stuyver, L., “Genotypes and genetic variation of hepatitis c virus. The molecular medicine of viral hepatitis”, en T.J. Harrison y A.J. Zuckerman (eds.), Chichester, Gran Bretana, John Wiley & Sons, 1997, pp. 182-233.

26. “Manual de instrucciones del estuche Linear Array Hepatitis c Virus Genotyping Test”, Roche Molecular Systems, 2005.

27. Tsukiyama-Kohara, K., Yamaguchi, K., Maki, N., Ohta, Y., Miki, K., Mizokami, M., Ohba, K.I. et al., “Antigenicity of group i and ii hepatitis c virus polypeptides-molecular basis of diagnosis”, Virology, 1993, 192: 430-437.

28. Dixit, V., Quan, S., Martin, P., Larson, D., Brezina, M., DiNello, R., Sra, K. et al., “Evaluation of a novel genotyping system for hepatitis c virus: strong correlation with standard genotyping methodologies”, J Clin Microbiol, 1995, 33: 2978-2983.

29. Kobayashi, M., Chayana, K., Arase, Y., Tsubota, A., Saitoh, S., Suzuki, Y., Ikeda, K. et al., “Enzyme-linked immunosorbent assay to detect hepatitis c virus serological groups 1 to 6”, J Gastroenterol, 1999, 34: 505-509.

30. Leruez-Ville, M., Nguyen, Q.T., Cohen, P., Cocco, S., Nouyou, M., Ferriere, F. y Deny, P., “Large-scale analysis of hepatitis c virus serological typing assay: effectiveness and limits”, J Med Virol, 1998, 55: 18-23.

31. Gish, R.G., Qian, K.P., Quan, S., Xu, Y.L., Pike, I., Polito, A., Di-Nello, R. et al., “Concordance between hepatitis c virus serotyping assays. J Viral Hepatol 1997; 4: 421-422.

32. Lefrere, J.J., Guiramand, S., Lefrere, F.F., Mariotti, M., Aumont, P., Lerable, J., Petit, J.C. et al., “Full or partial seroreversion in patients infected by hepatitis c virus”, J Infect Dis, 1997, 175: 316-322.